How to manage CKD with pregnancy?

Question

Hello doctor,

I am 31 years old and recently discovered that I am pregnant, currently at five weeks. I have had stage 3 chronic kidney disease (CKD) for a few years and am taking medications for blood pressure and phosphate control. I understand that pregnancy can place additional stress on the kidneys. The medications I currently take include antihypertensives and phosphate binders, but I would like to confirm whether these are safe during pregnancy. I seek your guidance on the best approach to ensure both maternal and fetal health.

Am I at risk of worsening kidney function or experiencing early delivery?
Should I be followed by a nephrologist throughout my pregnancy?

Kindly help.

Answer 1

Hello,

Welcome to icliniq.com.

I have read your query and can understand your concern.

Congratulations on your pregnancy!

With stage 3 chronic kidney disease (CKD), it is very important to approach pregnancy with close medical monitoring. However, many women in your situation go on to have healthy pregnancies with the right care. Yes, pregnancy can place additional stress on the kidneys, and women with stage 3 CKD are at higher risk for complications, including worsening kidney function.

High blood pressure or preeclampsia.
Preterm delivery.
Low birth weight.

Because of these potential risks, it is strongly recommended that you are closely followed by a nephrologist throughout your pregnancy, along with a high-risk obstetrician (maternal-fetal medicine specialist). Together, they will monitor your kidney function, blood pressure, electrolytes, and medication safety. Many antihypertensive medications, such as Labetalol (beta blocker) or Methyldopa (alpha-2 adrenergic agonist), are considered safer alternatives during pregnancy, but angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) must generally be discontinued.

Similarly, phosphate control medications such as Sevelamer (phosphate binder) or calcium acetate (phosphate binder) may need dose adjustments, and safety should be reviewed case-by-case. Early review of your current treatment plan is essential to ensure both fetal safety and ongoing kidney protection.

Regular laboratory tests and fetal growth monitoring will help track your health and your baby’s development throughout the pregnancy. With the right multidisciplinary care, early planning, and continuous monitoring, you can maximize the chances of a positive outcome for both you and your baby.

I hope this information helps you.

Feel free to ask further queries.